• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阴道微生物群、生殖器炎症和肿瘤形成会影响宫颈阴道微环境中的免疫检查点蛋白谱。

Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment.

作者信息

Łaniewski Paweł, Cui Haiyan, Roe Denise J, Chase Dana M, Herbst-Kralovetz Melissa M

机构信息

Department of Basic Medical Sciences, College of Medicine-Phoenix, University of Arizona, Phoenix, AZ USA.

UA Cancer Center, University of Arizona, Phoenix/Tucson, AZ USA.

出版信息

NPJ Precis Oncol. 2020 Aug 3;4:22. doi: 10.1038/s41698-020-0126-x. eCollection 2020.

DOI:10.1038/s41698-020-0126-x
PMID:32802959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7398915/
Abstract

Emerging evidence suggests that the vaginal microbiota play a role in HPV persistence and cervical neoplasia development and progression. Here we examine a broad range of immune checkpoint proteins in the cervicovaginal microenvironment across cervical carcinogenesis and explore relationships among these key immunoregulatory proteins, the microbiota composition, and genital inflammation. First, we demonstrate that immune checkpoint molecules can be measured in cervicovaginal lavages. Secondly, we identify CD40, CD27, and TIM-3 to specifically discriminate cervical cancer from other groups and CD40, CD28, and TLR2 to positively correlate to genital inflammation. Finally, PD-L1 and LAG-3 levels negatively, whereas TLR2 positively correlate to health-associated dominance. Overall, our study identifies immune checkpoint signatures associated with cervical neoplasm and illuminates the multifaceted microbiota-host immunity network in the local microenvironment. This study provides a foundation for future mechanistic studies and highlights the utility of cervicovaginal lavage profiling for predicting and monitoring response to cancer therapy.

摘要

新出现的证据表明,阴道微生物群在人乳头瘤病毒(HPV)持续感染以及宫颈癌变的发生和发展中起作用。在此,我们研究了宫颈癌发生过程中宫颈阴道微环境中广泛的免疫检查点蛋白,并探讨了这些关键免疫调节蛋白、微生物群组成和生殖器炎症之间的关系。首先,我们证明免疫检查点分子可在宫颈阴道灌洗液中检测到。其次,我们确定CD40、CD27和TIM-3可特异性区分宫颈癌与其他组,而CD40、CD28和TLR2与生殖器炎症呈正相关。最后,程序性死亡受体配体1(PD-L1)和淋巴细胞激活基因3(LAG-3)水平呈负相关,而TLR2与健康相关的优势菌群呈正相关。总体而言,我们的研究确定了与宫颈癌相关的免疫检查点特征,并阐明了局部微环境中多方面的微生物群-宿主免疫网络。本研究为未来的机制研究奠定了基础,并突出了宫颈阴道灌洗分析在预测和监测癌症治疗反应方面的效用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/040a7e7bae9b/41698_2020_126_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/1f834f69f290/41698_2020_126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/5c2ef2c917ad/41698_2020_126_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/aa85b2ed91e5/41698_2020_126_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/2ee679c78813/41698_2020_126_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/09c89653b4ad/41698_2020_126_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/c4c2d1f118ab/41698_2020_126_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/040a7e7bae9b/41698_2020_126_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/1f834f69f290/41698_2020_126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/5c2ef2c917ad/41698_2020_126_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/aa85b2ed91e5/41698_2020_126_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/2ee679c78813/41698_2020_126_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/09c89653b4ad/41698_2020_126_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/c4c2d1f118ab/41698_2020_126_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b69/7398915/040a7e7bae9b/41698_2020_126_Fig7_HTML.jpg

相似文献

1
Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment.阴道微生物群、生殖器炎症和肿瘤形成会影响宫颈阴道微环境中的免疫检查点蛋白谱。
NPJ Precis Oncol. 2020 Aug 3;4:22. doi: 10.1038/s41698-020-0126-x. eCollection 2020.
2
Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition.宫颈阴道 DNA 病毒组的改变与生殖器炎症和微生物群组成有关。
mSystems. 2022 Apr 26;7(2):e0006422. doi: 10.1128/msystems.00064-22. Epub 2022 Mar 28.
3
Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling.通过宫颈阴道代谢组学解析微生物群、HPV、炎症和癌症之间的复杂相互作用。
EBioMedicine. 2019 Jun;44:675-690. doi: 10.1016/j.ebiom.2019.04.028. Epub 2019 Apr 24.
4
Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis.宫颈阴道微环境特征驱动宫颈癌发生过程中患者的癌症生物标志物特征。
Sci Rep. 2019 May 14;9(1):7333. doi: 10.1038/s41598-019-43849-5.
5
Multi-omics data integration reveals metabolome as the top predictor of the cervicovaginal microenvironment.多组学数据整合揭示代谢组学是预测宫颈阴道微环境的首要因素。
PLoS Comput Biol. 2022 Feb 23;18(2):e1009876. doi: 10.1371/journal.pcbi.1009876. eCollection 2022 Feb.
6
Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women.在非西班牙裔和西班牙裔女性的宫颈癌发病机制中,连接宫颈阴道免疫特征、HPV 和微生物群落组成。
Sci Rep. 2018 May 15;8(1):7593. doi: 10.1038/s41598-018-25879-7.
7
An analysis of the vaginal microbiota and cervicovaginal metabolomics in cervical lesions and cervical carcinoma.宫颈病变和宫颈癌中阴道微生物群与宫颈阴道代谢组学的分析
Heliyon. 2024 Jun 22;10(13):e33383. doi: 10.1016/j.heliyon.2024.e33383. eCollection 2024 Jul 15.
8
Inflammatory cytokines and a diverse cervicovaginal microbiota associate with cervical dysplasia in a cohort of Hispanics living in Puerto Rico.在波多黎各居住的西班牙裔人群队列中,炎症细胞因子和多样化的宫颈阴道微生物群与宫颈发育不良相关。
PLoS One. 2023 Dec 8;18(12):e0284673. doi: 10.1371/journal.pone.0284673. eCollection 2023.
9
The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).HPV、其他性传播感染和生殖道微生物组在宫颈微环境中的相互作用(MicroCervixHPV 研究)。
Front Cell Infect Microbiol. 2024 Mar 12;13:1251913. doi: 10.3389/fcimb.2023.1251913. eCollection 2023.
10
The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer.宫颈阴道和肠道微生物群在宫颈上皮内瘤变和宫颈癌中的作用
J Immunother Precis Oncol. 2020 Sep 14;4(2):72-78. doi: 10.36401/JIPO-20-17. eCollection 2021 May.

引用本文的文献

1
Distinct cervical microbiome and metabolite profiles before and after menopause: implications for cervical cancer progression.绝经前后不同的宫颈微生物群和代谢物谱:对宫颈癌进展的影响。
Front Cell Infect Microbiol. 2025 Jul 16;15:1589277. doi: 10.3389/fcimb.2025.1589277. eCollection 2025.
2
Correlation analysis between vaginal microecology and high-risk human papillomavirus (HR-HPV)-positive cervical squamous intraepithelial lesions (SIL).阴道微生态与高危型人乳头瘤病毒(HR-HPV)阳性宫颈鳞状上皮内病变(SIL)的相关性分析
Medicine (Baltimore). 2025 Jul 4;104(27):e42914. doi: 10.1097/MD.0000000000042914.
3

本文引用的文献

1
Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients.可溶性免疫检查点相关蛋白作为预测透明细胞肾细胞癌患者肿瘤复发、生存和 T 细胞表型的标志物。
J Immunother Cancer. 2019 Nov 29;7(1):334. doi: 10.1186/s40425-019-0810-y.
2
A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer.多种癌症肿瘤浸润性T细胞上关键免疫检查点受体的综合分析
Front Oncol. 2019 Oct 25;9:1066. doi: 10.3389/fonc.2019.01066. eCollection 2019.
3
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial.
Vaginal Microbiota and Local Immunity in HPV-Induced High-Grade Cervical Dysplasia: A Narrative Review.
人乳头瘤病毒诱导的高级别宫颈发育异常中的阴道微生物群与局部免疫:一项叙述性综述
Int J Mol Sci. 2025 Apr 22;26(9):3954. doi: 10.3390/ijms26093954.
4
Viral oncogenesis in cancer: from mechanisms to therapeutics.癌症中的病毒致癌作用:从机制到治疗
Signal Transduct Target Ther. 2025 May 12;10(1):151. doi: 10.1038/s41392-025-02197-9.
5
Omics sciences for cervical cancer precision medicine from the perspective of the tumor immune microenvironment.从肿瘤免疫微环境角度看宫颈癌精准医学的组学科学
Oncol Res. 2025 Mar 19;33(4):821-836. doi: 10.32604/or.2024.053772. eCollection 2025.
6
The inferred modulation of correlated vaginal microbiota and metabolome by cervical differentially expressed genes across distinct CIN grades.不同CIN分级中宫颈差异表达基因对相关阴道微生物群和代谢组的推断调控。
BMC Microbiol. 2025 Apr 2;25(1):189. doi: 10.1186/s12866-025-03922-8.
7
Processing-bias correction with DEBIAS-M improves cross-study generalization of microbiome-based prediction models.使用DEBIAS-M进行处理偏差校正可提高基于微生物组的预测模型的跨研究泛化能力。
Nat Microbiol. 2025 Apr;10(4):897-911. doi: 10.1038/s41564-025-01954-4. Epub 2025 Mar 27.
8
Mapping the HPV Landscape in South African Women: A Systematic Review and Meta-Analysis of Viral Genotypes, Microbiota, and Immune Signals.绘制南非女性人乳头瘤病毒图谱:病毒基因型、微生物群和免疫信号的系统评价与荟萃分析
Viruses. 2024 Dec 8;16(12):1893. doi: 10.3390/v16121893.
9
Cervicovaginal Metabolome and Tumor Characteristics for Endometrial Cancer Detection and Risk Stratification.宫颈阴道代谢组学与肿瘤特征在子宫内膜癌检测和风险分层中的应用。
Clin Cancer Res. 2024 Jul 15;30(14):3073-3087. doi: 10.1158/1078-0432.CCR-23-2934.
10
CD40/CD40L expression and its prognostic value in cervical cancer.CD40/CD40L 的表达及其在宫颈癌中的预后价值。
Braz J Med Biol Res. 2023 Nov 13;56:e13047. doi: 10.1590/1414-431X2023e13047. eCollection 2023.
尼伏鲁单抗单药治疗复发性或转移性宫颈癌、阴道癌或外阴癌的安全性和疗效:来自 I/II 期 CheckMate 358 试验的结果。
J Clin Oncol. 2019 Nov 1;37(31):2825-2834. doi: 10.1200/JCO.19.00739. Epub 2019 Sep 5.
4
CD40 Agonist Antibodies in Cancer Immunotherapy.CD40 激动剂抗体在癌症免疫治疗中的应用。
Annu Rev Med. 2020 Jan 27;71:47-58. doi: 10.1146/annurev-med-062518-045435. Epub 2019 Aug 14.
5
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma.肠道微生物组影响肝癌患者对抗 PD-1 免疫治疗的反应。
J Immunother Cancer. 2019 Jul 23;7(1):193. doi: 10.1186/s40425-019-0650-9.
6
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.人群水平影响和 herd 效应:人乳头瘤病毒疫苗接种计划引入后的更新系统评价和荟萃分析。
Lancet. 2019 Aug 10;394(10197):497-509. doi: 10.1016/S0140-6736(19)30298-3. Epub 2019 Jun 26.
7
Associations of Cervicovaginal Lactobacilli With High-Risk Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia, and Cancer: A Systematic Review and Meta-Analysis.宫颈阴道乳杆菌与高危型人乳头瘤病毒感染、宫颈上皮内瘤变和宫颈癌的相关性:系统评价和荟萃分析。
J Infect Dis. 2019 Sep 13;220(8):1243-1254. doi: 10.1093/infdis/jiz325.
8
The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis.阴道微生物群、人乳头瘤病毒与宫颈发育不良:系统评价与网络荟萃分析。
BJOG. 2020 Jan;127(2):171-180. doi: 10.1111/1471-0528.15854. Epub 2019 Jul 17.
9
Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis.宫颈阴道微环境特征驱动宫颈癌发生过程中患者的癌症生物标志物特征。
Sci Rep. 2019 May 14;9(1):7333. doi: 10.1038/s41598-019-43849-5.
10
Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling.通过宫颈阴道代谢组学解析微生物群、HPV、炎症和癌症之间的复杂相互作用。
EBioMedicine. 2019 Jun;44:675-690. doi: 10.1016/j.ebiom.2019.04.028. Epub 2019 Apr 24.